The Effect of Teriparatide for the Treatment of Multiple Spontaneous Clinical Vertebral Fractures after Discontinuation of Denosumab in a Female Patient with Rheumatoid Arthritis: A Case Report-Reference-Cited by-同舟云学术

The Effect of Teriparatide for the Treatment of Multiple Spontaneous Clinical Vertebral Fractures after Discontinuation of Denosumab in a Female Patient with Rheumatoid Arthritis: A Case Report

Published:2021 Issue:1 Volume:254 Page:57-61
ISSN:0040-8727
Container-title:The Tohoku Journal of Experimental Medicine
language:en
Short-container-title:Tohoku J. Exp. Med.

Author:

Mori Yu¹,Izumiyama Takuya¹,Mori Naoko²,Aizawa Toshimi¹

Affiliation:

1. Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine

2. Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/tjem/254/1/254_57/_pdf

Reference28 articles.

1. Anastasilakis, A.D., Evangelatos, G., Makras, P. & Iliopoulos, A. (2020) Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation. Bone Rep., 12, 100267.

2. Anastasilakis, A.D., Polyzos, S.A., Makras, P., Trovas, G., Yavropoulou,M.P. & Tournis, S. (2021) Efficacy of antiosteoporotic medications in patients with rebound-associated fractures after denosumab discontinuation. J. Clin. Densitom., doi: 10.1016/j.jocd.2021.01.006. [Epub ahead of print].

3. Bone, H.G., Bolognese, M.A., Yuen, C.K., Kendler, D.L., Miller, P.D., Yang, Y.C., Grazette, L., San Martin, J. & Gallagher, J.C. (2011) Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J. Clin. Endocrinol. Metab., 96, 972-980.

4. Bone, H.G., Bolognese, M.A., Yuen, C.K., Kendler, D.L., Wang, H., Liu, Y. & San Martin, J. (2008) Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. J. Clin. Endocrinol. Metab., 93, 2149-2157.

5. Bone, H.G., Wagman, R.B., Brandi, M.L., Brown, J.P., Chapurlat, R., Cummings, S.R., Czerwinski, E., Fahrleitner-Pammer, A., Kendler, D.L., Lippuner, K., Reginster, J.Y., Roux, C., Malouf, J., Bradley, M.N., Daizadeh, N.S., et al. (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol., 5, 513-523.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the Editor from Mori and Mori: “Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis”;The Journal of Clinical Endocrinology & Metabolism;2024-02-09

3. Denosumab;Reactions Weekly;2022-01

4. Interstitial lung disease in a woman with rheumatoid arthritis treated with denosumab: A case report;Modern Rheumatology Case Reports;2021-11-17